#Single-use bioprocessing

[market-insider]

Single-Use Bioprocessing Market in the Quest for Efficient Biopharmaceutical Production

The global single-use bioprocessing market size is projected to reach USD 80.13 million by 2030, registering a compound annual growth rate (CAGR) of 16.24% over the forecast period, according to a new report by Grand View Research, Inc. The demand for single-use bioprocessing offerings is driven by the commercial advantages offered, including a reduction in costs and time required for bioprocessing operations. Originally used for monoclonal antibody production, single-use technologies are also gaining traction for cell and gene therapy manufacturing. As a result, broadening the scope of applications in biomanufacturing operations is likely to drive industry growth.

Single-use Bioprocessing Market Report Highlights

The simple & peripheral elements segment held the largest share in 2023 due to the significant adoption of these products as a result of a variety of customizable options available for bioprocessing applications

The upstream bioprocessing workflow segment accounted for the largest share in 2023. Continuous developments and betterment in technologies for upstream bioprocessing are driving the segment growth

North America was the leading region in 2023 due to the high R&D spending and growth of the biopharmaceutical manufacturing sector in the region

Furthermore, the presence of key players, such as Thermo Fisher Scientific, Inc. and Danaher Corp., is driving the regional market

The biopharmaceutical manufacturers end-use segment dominated the industry in 2023 and accounted for the maximum revenue share. This was due to the high demand for biologics and heavy investments in cell & gene therapy manufacturing

For More Details or Sample Copy please visit link @: Single-use Bioprocessing Market Report

Furthermore, strategic initiatives from key players are expanding the industry's growth prospects. For instance, in July 2021, Cytiva and Pall Corp. announced investment plans for capacity expansion over two years. Among other key products, more than USD 300 million were invested in single-use technologies, such as bioreactor bags for cell expansion, used to make personalized therapies and syringe filters for scientific research. Similarly, the growing adoption of single-use equipment for in-house and contract manufacturing has opened new avenues for the flow of investments in this space. The industry is witnessing significant advancements in several product portfolios, including disposable probes and sensors, stirring systems, bioreactor designs, and filtration technologies, which are expected to contribute to strong revenue growth.

The benefits offered by single-use bioprocessing systems have enabled biopharmaceutical manufacturers to offer their products faster to the market by introducing multi-product facilities, entering into partnerships, or outsourcing pipeline products for contract development and manufacturing. For instance, in January 2021, Sartorius AG partnered with RoosterBio, a leading supplier of human Mesenchymal Stem/Stromal Cells (hMSC). This collaboration aimed at advancing cell & gene therapy manufacturing by leveraging the single-use manufacturing technologies from Sartorius AG. The COVID-19 pandemic has generated new growth opportunities for key stakeholders in the industry.

[cihealthinsightshub]

Sustainable Bioprocessing Gains Ground with Recyclable Single-Use Systems

The Single-use Bioprocessing Market is entering a transformative growth phase, fueled by the rapid expansion of biopharmaceutical manufacturing, rising demand for flexible production systems, and heightened focus on contamination control. Valued at USD 7.62 billion in 2021, the market is projected to reach USD 25.40 billion by 2031, growing at an impressive CAGR of 18.93% during the forecast period (2024–2031).

Unlock exclusive insights with our detailed sample report :

This market is evolving rapidly with the increasing adoption of single-use bioprocessing systems such as bioreactors, fermenters, mixers, filtration units, bags, and containers. These disposable systems, primarily made of sterilizable plastic components, support critical processes like upstream expression, purification, storage, and separation of biopharmaceutical products. As global biomanufacturing shifts toward agile, cost-effective, and contamination-free solutions, single-use technologies are being embraced by both established pharma giants and emerging biotech firms—especially in alignment with trends seen in the United States and Asia, where scalable, single-use systems are driving next-gen biologics production.

Key Market Drivers

1. Rise in Biologics and Personalized Medicine: The growth of monoclonal antibodies, gene therapy, and personalized medicine has created a strong need for scalable, contamination-free, and faster bioprocessing methods. Single-use systems (SUS) offer agility and ease of implementation, making them ideal for such advanced therapies.

2. Cost Efficiency and Operational Flexibility: Unlike traditional stainless-steel systems, SUS eliminate the need for cleaning and sterilization, significantly reducing downtime and water/chemical usage. This makes them highly attractive for small-to-mid-sized biotech firms and contract manufacturing organizations (CMOs).

3. Pandemic Preparedness and Vaccine Development: COVID-19 and subsequent global health threats highlighted the urgent need for rapid-response manufacturing capabilities. Single-use systems enabled fast-tracked vaccine production and played a pivotal role in scaling mRNA technologies.

4. Regulatory and Environmental Incentives: The U.S. FDA and EMA support the adoption of single-use bioreactors and modular facilities, facilitating market expansion. Meanwhile, vendors are innovating biodegradable materials to tackle concerns over plastic waste and sustainability.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements:

Market Segmentation Snapshot

By Product Type: The market is segmented into bioreactors, mixers, bags, tubes & connectors, sampling systems, and others. Bioreactors and mixing systems account for the largest share due to their central role in upstream processing.

By Workflow: Upstream processing dominates the market share, given the high usage of SUS in cell culture and fermentation.

By End-User: Biopharmaceutical companies hold the majority share, followed by CMOs and academic research institutes.

Regional Insights

United States: The U.S. remains the largest and most mature market, fueled by robust biopharma R&D, government funding, and large-scale manufacturing investments. In 2024, the U.S. government announced a new initiative to strengthen domestic biologics production, allocating over USD 2 billion toward advanced manufacturing platforms—predominantly single-use facilities. Leading companies like Thermo Fisher Scientific, Danaher Corporation, and Sartorius Stedim Biotech are expanding their manufacturing capacities across North America.

Japan: Japan’s biopharma industry is rapidly integrating single-use systems as part of its strategic vision for regenerative medicine and mRNA vaccine production. In 2024, the Japanese Ministry of Health, Labour and Welfare (MHLW) introduced incentives for companies transitioning from conventional systems to disposable solutions. Furthermore, leading Japanese firms such as Asahi Kasei and Nipro Corporation are increasing R&D spending on sustainable single-use materials to enhance product lifecycle management.

Europe and Asia-Pacific: Germany, the UK, and Switzerland continue to be innovation hubs, while emerging economies in the Asia-Pacific region, such as China, South Korea, and India, are rapidly adopting SUS to scale biologics and biosimilars production.

Latest Industry Trends

AI Integration in Bioprocess Monitoring: Vendors are now embedding AI and data analytics into SUS platforms to allow predictive maintenance, batch tracking, and process optimization.

Modular Biomanufacturing Units: Companies are investing in mobile, modular units using SUS to cater to outbreak hotspots and rural regions, enhancing supply chain agility.

Green Bioprocessing Innovations: Environmental concerns are driving innovations in recyclable polymers and closed-loop systems to minimize single-use plastic waste.

M&A Activity on the Rise: The market is witnessing increased mergers and acquisitions. For example, in Q1 2025, Repligen Corporation announced the acquisition of a European tubing and bagging system manufacturer to strengthen its product portfolio.

Buy the exclusive full  report here:

Competitive Landscape

The market is highly competitive and fragmented, with major players focusing on product innovation, capacity expansion, and strategic partnerships. Notable players include:

Thermo Fisher Scientific Inc.

Sartorius AG

Danaher Corporation (Cytiva and Pall)

Merck KGaA

Eppendorf AG

Parker Hannifin Corp.

Avantor, Inc.

Corning Incorporated

PBS Biotech, Inc.

Saint-Gobain Performance Plastics

These companies are investing in next-generation single-use assemblies, automation, and flexible manufacturing to meet evolving industry demands.

Growth Opportunities

CMO & CDMO Expansion: As pharmaceutical outsourcing grows, CMOs are increasingly deploying SUS to reduce turnaround time and manage multiple client processes efficiently.

Biosimilar Production: The patent cliff for blockbuster biologics has opened lucrative opportunities for biosimilars, where SUS offers a cost-effective pathway to scale.

Emerging Markets Penetration: Expansion in Latin America, Southeast Asia, and Africa presents a significant untapped opportunity, supported by international funding agencies.

Regenerative Medicine and Cell Therapy: As cell therapy and tissue engineering progress, single-use bioreactors and closed systems will be pivotal in clinical and commercial scale-up.

Stay informed with the latest industry insights-start your subscription now:

Conclusion

The global single-use bioprocessing market is on the cusp of a revolution, catalyzed by innovation in biologics, operational efficiency, and a growing preference for flexible, scalable manufacturing. The United States and Japan stand at the forefront of this transformation, while global demand signals a sustained, long-term market boom. As regulatory and environmental concerns are addressed through innovation, single-use technologies are poised to become the new standard in biopharmaceutical manufacturing.

[healthcare-updates-with-sns]

Single-use Bioprocessing Market: Market Trends and Market Growth 2024-2032

The Single-use Bioprocessing Market Size was valued at USD 26.8 Billion in 2023 and is expected to reach USD 100.9 Billion by 2032, growing at a CAGR of 15.9% over the forecast period 2024-2032. This growth is driven by the increasing demand for biopharmaceuticals, advancements in single-use technology, and a shift toward cost-effective and flexible manufacturing solutions.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3661

Market Segmentation

By Product:

Simple & Peripheral Elements: Tubing, filters, connectors, transfer systems, bags, sampling systems, probes, sensors (pH, oxygen, pressure, temperature, conductivity, flow), and others.

Apparatus & Plants: Bioreactors (up to 1000L, 1000L-2000L, above 2000L), mixing, storage, filling systems, filtration systems, chromatography systems, pumps, and others.

Work Equipment: Cell culture systems, syringes, and others.

By Workflow:

Upstream bioprocessing

Fermentation

Downstream bioprocessing

By End-use:

Biopharmaceutical Manufacturers: CMOs & CROs, in-house manufacturers.

Academic & Clinical Research Institutes.

Regional Analysis

North America: Held the largest market share in 2023, driven by a strong biopharmaceutical sector, significant investments in research, and government support for biomanufacturing.

Asia-Pacific: Expected to witness the fastest growth due to rising healthcare investments, an expanding biopharmaceutical industry, and increased adoption of single-use technologies in manufacturing. Countries like China and India are playing a crucial role in market expansion.

Key Players

Service Providers / Manufacturers:

Thermo Fisher Scientific (HyPerforma Single-Use Bioreactors, BioProcess Containers)

Sartorius AG (Biostat STR Bioreactors, Flexsafe Bags)

Merck KGaA (Ultimus Film, Mobius Single-Use Systems)

Danaher Corporation (Xcellerex Bioreactors, Pall Allegro Systems)

GE Healthcare Life Sciences (Xcellerex XDR Bioreactors, WAVE Bioreactor Systems)

Eppendorf AG (BioBLU Single-Use Vessels, CelliGen BLU Bioreactors)

Corning Incorporated (HYPERStack Cell Culture Vessels, CellCube Modules)

Avantor, Inc. (J.T.Baker BPCs, Single-Use Mixer Systems)

Cellexus International (CellMaker Plus, CellMaker Regular)

Lonza Group AG (MODA-ES Bioprocess Software, Nunc Cell Factory Systems)

Key Market Trends

Growing demand for biologics, including vaccines and monoclonal antibodies.

Continuous technological advancements improving efficiency and scalability.

Increasing government support for biopharmaceutical manufacturing infrastructure.

Cost-effectiveness and flexibility of single-use systems compared to traditional stainless-steel setups.

Challenges include concerns over material leachables and extractables, as well as the need for standardization across single-use designs.

Future Scope

The single-use bioprocessing market is set for transformative growth, driven by the rising adoption of biologics and cell & gene therapies. Hybrid systems combining single-use and stainless-steel technologies are emerging to address scalability challenges. Moreover, the expansion into emerging markets presents substantial opportunities, as the demand for flexible and cost-efficient biomanufacturing solutions continues to rise.

Conclusion

The single-use bioprocessing market is undergoing rapid evolution, fueled by technological advancements and increasing global demand for biologics. While challenges related to standardization and material concerns remain, ongoing innovations and strategic investments will further strengthen the role of single-use technologies in the future of biopharmaceutical manufacturing.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Fertility Services Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

[global-research-report]

Global Single-Use Bioprocessing Market: Trends, Challenges, and Strategic Forecasts

The global single-use bioprocessing market size is projected to reach USD 80.13 billion by 2030, registering a compound annual growth rate (CAGR) of 16.24% over the forecast period, according to a new report by Grand View Research, Inc. The demand for single-use bioprocessing offerings is driven by the commercial advantages offered, including a reduction in costs and time required for bioprocessing operations. Originally used for monoclonal antibody production, single-use technologies are also gaining traction for cell and gene therapy manufacturing. As a result, broadening the scope of applications in biomanufacturing operations is likely to drive industry growth.

Furthermore, strategic initiatives from key players are expanding the industry's growth prospects. For instance, in July 2021, Cytiva and Pall Corp. announced investment plans for capacity expansion over two years. Among other key products, more than USD 300 million were invested in single-use technologies, such as bioreactor bags for cell expansion, used to make personalized therapies and syringe filters for scientific research. Similarly, the growing adoption of single-use equipment for in-house and contract manufacturing has opened new avenues for the flow of investments in this space. The industry is witnessing significant advancements in several product portfolios, including disposable probes and sensors, stirring systems, bioreactor designs, and filtration technologies, which are expected to contribute to strong revenue growth.

The benefits offered by single-use bioprocessing systems have enabled biopharmaceutical manufacturers to offer their products faster to the market by introducing multi-product facilities, entering into partnerships, or outsourcing pipeline products for contract development and manufacturing. For instance, in January 2021, Sartorius AG partnered with RoosterBio, a leading supplier of human Mesenchymal Stem/Stromal Cells (hMSC). This collaboration aimed at advancing cell & gene therapy manufacturing by leveraging the single-use manufacturing technologies from Sartorius AG. The COVID-19 pandemic has generated new growth opportunities for key stakeholders in the industry.

Key biopharmaceutical players can leverage the opportunity by expanding their COVID-19-related product offerings by scaling up their production facilities with the implementation of single-use bioprocessing equipment. A significant number of biopharmaceutical companies are actively involved in the development and production of COVID-19 vaccines. These programs are majorly based on single-use technologies as these systems are flexible, cost-effective, and reduce the risk of cross-contamination. Such an ongoing and continuous increase in the adoption of bioprocessing systems due to the COVID-19 pandemic is anticipated to drive industry growth.

Single-use Bioprocessing Market Report Highlights

The simple & peripheral elements segment held the largest share in 2023 due to the significant adoption of these products as a result of a variety of customizable options available for bioprocessing applications

The upstream bioprocessing workflow segment accounted for the largest share in 2023. Continuous developments and betterment in technologies for upstream bioprocessing are driving the segment growth

North America was the leading region in 2023 due to the high R&D spending and growth of the biopharmaceutical manufacturing sector in the region

Furthermore, the presence of key players, such as Thermo Fisher Scientific, Inc. and Danaher Corp., is driving the regional market

The biopharmaceutical manufacturers end-use segment dominated the industry in 2023 and accounted for the maximum revenue share. This was due to the high demand for biologics and heavy investments in cell & gene therapy manufacturing

Single-use Bioprocessing Market Segmentation

Grand View Research has segmented the global single-use bioprocessing market based on product, workflow, end-use, and region:

Single-use Bioprocessing By Product Outlook (Revenue, USD Million, 2018 - 2030)

Simple & Peripheral Elements

Tubing, Filters, Connectors, & Transfer Systems

Bags

Sampling Systems

Probes & Sensors

pH Sensor

Oxygen Sensor

Pressure Sensors

Temperature Sensors

Conductivity Sensors

Flow Sensors

Others

Others

Apparatus & Plants

Bioreactors

Upto 1000L

Above 1000L to 2000L

Above 2000L

Mixing, Storage, & Filling Systems

Filtration System

Chromatography Systems

Pumps

Others

Work Equipment

Cell Culture System

Syringes

Others

Single-use Bioprocessing By Workflow Outlook (Revenue, USD Million, 2018 - 2030)

Upstream Bioprocessing

Fermentation

Downstream Bioprocessing

Single-use Bioprocessing By End-use Outlook (Revenue, USD Million, 2018 - 2030)

Biopharmaceutical Manufacturers

CMOs & CROs

In-house Manufacturers

Academic & Clinical Research Institutes

Single-use Bioprocessing Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of key players

Sartorius AG

Danaher

Thermo Fisher Scientific, Inc.

Merck KGaA

Avantor, Inc.

Eppendorf SE

Corning Incorporated

Lonza

PBS Biotech, Inc.

Meissner Filtration Products, Inc.

Order a free sample PDF of the Single-use Bioprocessing Market Intelligence Study, published by Grand View Research.

[sfoxxlife]

Single-use Bioprocess Systems

Single-use bioprocess systems are revolutionizing the biotech and pharmaceutical industries by providing innovative solutions for efficient and contamination-free manufacturing. These systems are designed for one-time use, eliminating the need for extensive cleaning and sterilization, thus streamlining operations significantly.

What Are Single-Use Bioprocess Systems?

Single-use bioprocess systems refer to disposable devices and assemblies used in biopharmaceutical manufacturing. These include bioreactors, bags, tubing, filters, and connectors, made from sterilized, high-grade polymers.

Advantages of Single-Use Bioprocess Systems

Cost-Effectiveness:

Reduces expenses related to cleaning, sterilization, and labor.

Operational Flexibility:

Allows for quick setup and changeover between production batches.

Minimized Contamination Risk:

Being disposable, these systems significantly lower the chance of cross-contamination.

Applications in Bioprocessing

Pharmaceutical Manufacturing:

Essential for producing monoclonal antibodies and biologics.

Vaccine Production:

Critical during pandemic responses for rapid deployment.

Research and Development:

Provides flexibility for small-scale and pilot studies.

Single-Use Systems vs. Traditional Stainless-Steel Systems

Cleaning: Single-use systems eliminate cleaning requirements, unlike stainless steel systems.

Setup Time: They are quicker to deploy, enhancing production timelines.

Flexibility: Ideal for multi-product facilities, unlike fixed stainless-steel setups.

Types of Single-Use Bioprocess Systems

Single-Use Bioreactors:

For cultivating cells and microorganisms.

Mixing Systems:

Used to blend media and buffers.

Storage Bags:

Secure storage for intermediates and final products.

Key Materials Used in Single-Use Systems

High-quality polymers such as polyethylene and polypropylene are common.

These materials meet stringent regulatory standards to ensure biocompatibility and sterility.

Challenges in Adopting Single-Use Systems

Environmental Impact:

Disposal of plastics raises sustainability concerns.

Scalability:

While ideal for small to mid-scale, large-scale adoption can pose challenges.

Ensuring Quality in Single-Use Systems

Regulatory Standards: Compliance with FDA, EMA, and ISO guidelines is essential.

Validation Testing: Rigorous testing ensures product integrity and sterility.

Sustainability and Environmental Considerations

Companies are exploring recycling and biodegradable materials to mitigate environmental concerns.

Initiatives for a circular economy in bioprocessing are gaining momentum.

Trends in Single-Use Bioprocess Systems

Automation:

Integration with IoT and AI for monitoring and control.

Material Advancements:

Development of stronger, more sustainable polymers.

Factors to Consider When Choosing a Single-Use System

Compatibility: Ensure the system suits the specific bioprocess.

Vendor Support: Opt for reliable suppliers with proven track records.

Cost Analysis: Single-Use Systems vs. Reusable Systems

While the initial costs for single-use systems may seem higher, the savings on cleaning, labor, and downtime make them a cost-effective option over time.

Case Studies of Single-Use Systems in Action

COVID-19 Vaccine Production: Enabled rapid manufacturing and scalability.

Monoclonal Antibody Manufacturing: Improved efficiency and reduced contamination risks.

Future of Single-Use Bioprocess Systems

Expect more advanced materials and fully automated solutions.

Broader adoption across industries beyond biopharma, such as food and beverage processing.

FAQs

What industries benefit most from single-use systems?Industries like pharmaceuticals, biotechnology, and food processing find the most utility.

How are single-use systems disposed of?They are often incinerated or processed through specialized recycling programs.

Are single-use systems cost-efficient for small-scale processes?Yes, they are particularly beneficial for small and pilot-scale manufacturing due to reduced setup and cleaning costs.

What are the most common components of single-use bioprocess systems?Bioreactors, tubing, connectors, and storage bags are widely used components.

Can single-use systems support large-scale manufacturing?While more challenging, advancements in scalability are making it increasingly feasible.

Conclusion

Single-use bioprocess systems are a game-changer in modern manufacturing, offering unmatched flexibility, cost-efficiency, and contamination control. As the technology evolves, it will continue to redefine industry standards.

Contact Us : sales@foxxlifesciences.com

https://www.linkedin.com/company/foxxlifesciences

[adityarana1687-blog]

India Single-use Bioprocessing Probes And Sensors Market To Reach $191.0 Million By 2030

The India single-use bioprocessing probes and sensors market is anticipated to reach USD 191.0 million by 2030 and is anticipated to grow at a CAGR of 12.61% during the forecast period from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for biopharmaceuticals and the growing popularity of disposable systems in preclinical trials are key factors driving the growth of the single-use bioprocessing probes and sensors market in India. The need for faster and more efficient drug development processes and the rising demand for personalized medicines contribute to the increased implementation of single-use bioprocessing systems.

The implementation of single-use technology (SUT) in biomanufacturing processes offers advantages such as reduced risk of cross-contamination and ensuring product purity and integrity, which is crucial for the growing domestic biosimilars and biologics market. It enhances operational efficiency, leading to shorter turnaround times and increased productivity - a key benefit for Indian manufacturers to scale and meet the rising domestic and global demand for biopharmaceuticals.

Furthermore, the commercial advantages of single-use sensors, such as streamlined operations, enhanced flexibility, and improved regulatory compliance and product quality, make them an attractive option for Indian biomanufacturers. The adoption of these technologies can help Indian companies lower their capital expenditure and achieve faster turnaround times.

Request a free sample copy or view report summary: India Single-use Bioprocessing Probes And Sensors Market Report

India Single-use Bioprocessing Probes And Sensors Market Report Highlights

The pH sensors type segment held the largest revenue share of 20.24% in 2023 and is expected to grow at the fastest CAGR over the forecast period. The growing demand for precise process monitoring, driven by the expanding biopharmaceutical industry, drives the adoption of single-use pH sensors. The oxygen sensors segment is expected to register a significant CAGR over the forecast period.

The upstream segment dominated the segment with a market share of 73.49% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. It is driven by the increasing demand for biopharmaceuticals and the need for efficient and cost-effective manufacturing processes.

The biopharmaceutical & pharmaceutical companies dominated the segment with a market share of 41.69% in 2023. The consistent introduction of new and innovative single-use bioprocessing probes and sensors is a key driver behind the growth of this market segment.

India Single-use Bioprocessing Probes And Sensors Market Segmentation

Grand View Research has segmented the India single-use bioprocessing probes and sensors market based on type, workflow, and end use:

India Single-use Bioprocessing Probes And Sensors Type Outlook (Revenue, USD Million, 2018 - 2030)

pH Sensor

Oxygen Sensors

Pressure Sensors

Temperature Sensors

Conductivity Sensors

Flow Meter & Sensors

Other Sensors

India Single-use Bioprocessing Probes And Sensors Workflow Outlook (Revenue, USD Million, 2018 - 2030)

Upstream

pH Sensor

Oxygen Sensors

Pressure Sensors

Temperature Sensors

Conductivity Sensors

Flow Meter & Sensors

Other Sensors

Downstream

pH Sensor

Pressure Sensors

Temperature Sensors

Conductivity Sensors

Flow Meter & Sensors

Other Sensors

India Single-use Bioprocessing Probes And Sensors End-use Outlook (Revenue, USD Million, 2018 - 2030)

Biopharmaceutical & Pharmaceutical Companies

CROs & CMOs

Academic & Research Institutes

Others

List of Key Players in theIndia Single-use Bioprocessing Probes And Sensors Market

Thermo Fisher Scientific

Sartorius AG

PreSens Precision Sensing GmbH

Hamilton Company

Mettler-Toledo India Private Limited

PARKER HANNIFIN CORP

Danaher

Saint-Gobain

[luckydige45]

According to Nova One Advisor, the global single-use bioprocessing probes & sensors market size was valued at USD 3.85 billion in 2023 and is anticipated to reach around USD 11.27 billion by 2033, growing at a CAGR of 11.34% from 2024 to 2033.

[comparableau]

Single-use systems are biopharmaceutical production (bioprocessing) products that are only used once and then discarded. Single-use systems are often made up of plastic components that have been disinfected and sealed using gamma irradiation.

[marketreports-blog]

According to Nova One Advisor, the global single-use bioprocessing market size was estimated at USD 28.45 billion in 2023 and it is projected to increase USD 128.24 billion by 2033 with a CAGR of 16.25% from 2024 to 2033.

[vijukumar]

Navigating the Consumables Market: Trends, Growth, and Industry Insights

The Consumables Market is a dynamic and multifaceted sector that encompasses a wide range of industries, from healthcare to laboratories and beyond. In this blog post, we will explore key aspects of the Consumables Market, examining its various segments, growth drivers, and emerging trends.

Understanding the Consumables Market:

The Consumables Market is vast, covering a spectrum of industries such as healthcare, laboratories, and bioprocessing. The global Hospital Consumables market size was valued at USD 432561.2 million in 2022 and is expected to expand at a CAGR of 12.31% during the forecast period, reaching USD 868182.18 million by 2028. Hospital Consumables reference to frequently used accessories for hospitals. Its core essence lies in the supply of disposable products essential for daily operations, contributing to the efficiency and safety of various processes. Let's delve into some specific segments within the Consumables Market:

Dental Consumables Market: Dental consumables play a crucial role in dental care, ranging from disposable instruments to materials like crowns and braces. The dental consumables market is driven by technological advancements, an aging population, and a growing awareness of oral health.

Single-use Bioprocessing Market: Single-use bioprocessing consumables are gaining traction due to their cost-effectiveness and reduced risk of contamination. With the biopharmaceutical industry expanding, the demand for single-use bioprocessing solutions is on the rise.

Hospital Consumables Market: Hospitals rely heavily on consumables, including gloves, gowns, and medical supplies. The hospital consumables market is influenced by factors such as the increasing number of surgeries, the rise in healthcare infrastructure, and the emphasis on infection control.

Laboratory Consumables Market: Laboratories are critical hubs for research and testing, and consumables like pipettes, tubes, and slides are indispensable. The laboratory consumables market is driven by ongoing research and development activities, advancements in diagnostic technologies, and the demand for precision in testing.

Medical Consumables Market: The medical consumables market encompasses a broad spectrum, including wound care products, diagnostic kits, and infusion sets. Factors such as the global aging population, prevalence of chronic diseases, and advancements in healthcare infrastructure contribute to its growth.

Single-use Bioreactors Market: Single-use bioreactors are integral to biopharmaceutical manufacturing, offering flexibility and cost savings. The single-use bioreactors market is witnessing substantial growth, driven by the biopharmaceutical industry's expansion and the need for more efficient production processes.

Chromatography Consumables Market: Chromatography is a vital technique in analytical chemistry, and the consumables market associated with it includes columns, syringes, and filters. The chromatography consumables market is influenced by the increasing demand for precise analytical techniques in pharmaceuticals, food and beverage, and environmental testing.

Key Trends and Growth Drivers:

Technological Advancements: The Consumables Market is characterized by continuous technological advancements, such as the integration of smart technologies and the development of eco-friendly and sustainable consumables.

Increasing Healthcare Expenditure: With a growing emphasis on healthcare infrastructure globally, the demand for consumables in hospitals and medical facilities is on the rise, driving market growth.

Biopharmaceutical Industry Expansion: The biopharmaceutical industry's rapid growth, marked by increasing research and development activities, is a significant factor contributing to the expansion of the Consumables Market.

Focus on Single-Use Solutions: The shift towards single-use solutions, particularly in bioprocessing and biopharmaceutical manufacturing, is a prevailing trend due to cost-effectiveness and reduced risk of contamination.

Conclusion:

The Consumables Market is dynamic and responsive to the evolving needs of various industries. As technological innovations continue to shape the landscape, and industries like healthcare and biopharmaceuticals expand, the demand for consumables will remain robust. Stay tuned for further insights as we track the ever-changing Consumables Market landscape.

[materialsscienceandengineering]

A fungus converts cellulose directly into a novel platform chemical

The fungus Talaromyces verruculosus can produce the chemical erythro-isocitric acid directly from cheap plant waste, thus making it interesting for industrial utilization. Using the natural abilities of the non-genetically modified fungus, a research team from Jena has discovered a method for the efficient conversion of cellulose into a form of isocitric acid. The new production method could significantly simplify the previously complex and multi-stage process for obtaining platform chemicals from cellulose by requiring only a single bioprocess. Thanks to the new cost-effective method, the rarely utilized sister molecule of the intensively used citric acid can benefit a sustainable circular economy—provided there is a market for it. The study was published by a research team from the Leibniz Institute for Natural Product Research and Infection Biology—Hans Knöll Institute (Leibniz-HKI) in the journal ACS Sustainable Chemistry & Engineering.

Read more.

[luckydige45]

According to Nova One Advisor, the global single-use bioprocessing probes & sensors market size was valued at USD 3.85 billion in 2023 and is anticipated to reach around USD 11.27 billion by 2033, growing at a CAGR of 11.34% from 2024 to 2033.